1-6 of 6
Anita Rampersad
Close
Sort by
Journal Articles

Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial

Clinical Trials & Observations
Guillermo Garcia-Manero, Ghulam J. Mufti, Pierre Fenaux, Rena Buckstein, Valeria Santini, María Díez-Campelo, Carlo Finelli, Osman Ilhan, Mikkael A. Sekeres, Amer M. Zeidan, Rodrigo Ito, Jennie Zhang, Anita Rampersad, Daniel Sinsimer, Jay T. Backstrom, Uwe Platzbecker, Rami S. Komrokji
Journal: Blood
Blood (2022) 139 (4): 624–629.
https://doi.org/10.1182/blood.2021012589
Published: 2022
Journal Articles

Hematologic Improvement-Neutrophil and -Platelet in the MEDALIST Trial: Multilineage Data from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Guillermo Garcia-Manero, MD, Ghulam J. Mufti, Pierre Fenaux, MD PhD, Rena Buckstein, MD FRCPC, Valeria Santini, MD, María Díez-Campelo, MD PhD, Carlo Finelli, Mario Cazzola, MD, Osman Ilhan, Mikkael A. Sekeres, MD MS, Alan F. List, MD, Abderrahmane Laadem, Rodrigo Ito, Jennie Zhang, Anita Rampersad, Daniel Sinsimer, Peter G. Linde, Uwe Platzbecker, MD, Rami Komrokji
Journal: Blood
Blood (2019) 134 (Supplement_1): 4243.
https://doi.org/10.1182/blood-2019-123048
Published: 2019
Journal Articles

Luspatercept Significantly Reduces Red Blood Cell (RBC) Transfusion Burden, Regardless of Gene Mutation Frequency, Spectrum, and Prognostic Significance, Among Patients (Pts) with LR-MDS Enrolled in the MEDALIST Trial

Uwe Platzbecker, Diana Dunshee, Rami S. Komrokji, MD, Ghulam J. Mufti, Guillermo Garcia-Manero, MD, Rena Buckstein, MD FRCPC, Valeria Santini, MD, María Díez-Campelo, MD PhD, Mikkael A. Sekeres, MD MS, Wendy L. See, Kevin Tsai, Alberto Risueño, Jianglin Ma, Martin Schwickart, Anita Rampersad, Jennie Zhang, Abderrahmane Laadem, Daniel Menezes, Kyle MacBeth, PhD, Peter G. Linde, Joseph G. Reynolds, PhD, Alan F. List, MD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2999.
https://doi.org/10.1182/blood-2019-123655
Published: 2019
Journal Articles

Assessment of Longer-Term Efficacy and Safety in the Phase 3, Randomized, Double-Blind, Placebo-Controlled MEDALIST Trial of Luspatercept to Treat Anemia in Patients (Pts) with Revised International Prognostic Scoring System (IPSS-R) Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Pierre Fenaux, MD PhD, Ghulam J. Mufti, Rena Buckstein, MD FRCPC, Valeria Santini, MD, María Díez-Campelo, MD PhD, Carlo Finelli, Mario Cazzola, MD, Osman Ilhan, MD, Mikkael A. Sekeres, MD MS, Rami S. Komrokji, MD, Alan F. List, MD, Amer M. Zeidan, MBBS, MHS, Amit Verma, MBBS, Abderrahmane Laadem, Rodrigo Ito, Jennie Zhang, Anita Rampersad, Daniel Sinsimer, Peter G. Linde, Guillermo Garcia-Manero, MD, Uwe Platzbecker, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 841.
https://doi.org/10.1182/blood-2019-123064
Published: 2019
Journal Articles

The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Pierre Fenaux, MD PhD, Uwe Platzbecker, Ghulam J. Mufti, Guillermo Garcia-Manero, MD, Rena Buckstein, MD FRCPC, Valeria Santini, María Díez-Campelo, Carlo Finelli, MD, Mario Cazzola, Osman Ilhan, MD, Mikkael A. Sekeres, MD MS, José F. Falantes, Beatriz Arrizabalaga, MD PhD, Flavia Salvi, Valentina Giai, Paresh Vyas, David Bowen, MD PhD, Dominik Selleslag, MD, Amy E. DeZern, MD, Joseph G. Jurcic, MD, Ulrich Germing, MD, Katharina S. Götze, MD, Bruno Quesnel, Odile Beyne-Rauzy, Thomas Cluzeau, MD PhD, Maria Teresa Voso, Dominiek Mazure, Edo Vellenga, Peter L Greenberg, MD, Eva Hellström-Lindberg, MD PhD, Amer M. Zeidan, MBBS, MHS, Abderrahmane Laadem, MD, Aziz Benzohra, Jennie Zhang, Anita Rampersad, Peter G. Linde, Matthew L. Sherman, Rami S. Komrokji, MD, Alan F. List, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1.
https://doi.org/10.1182/blood-2018-99-110805
Published: 2018
Journal Articles

Phase 1b Dose-Escalation Study of Sonidegib (LDE225) in Combination with Ruxolitinib (INC424) in Patients with Myelofibrosis

Vikas Gupta, MD FRCP, FRCPath, Steffen Koschmieder, MD, Claire N. Harrison, DM, FRCP, FRCPath, Francisco Cervantes, MD PhD, Florian H Heidel, MD, Mark Drummond, MD PhD, Jerome Rey, MD, Eunju Hurh, PhD, Weichao Bao, PhD, Anita Rampersad, Stacey Kalambakas, MD, Alessandro Maria Vannucchi, MD
Journal: Blood
Blood (2014) 124 (21): 712.
https://doi.org/10.1182/blood.V124.21.712.712
Published: 2014